drugset / Trial / NCT02246517

The Effect of N2O on Chronic Neuropathic Pain Patients

NCT02246517

Phase 0 Unknown 20 enrolled Tel-Aviv Sourasky Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

Important pharmacological agents for treatment of chronic neuropathic pain such as ketamine block NMDA receptors. Nitrous oxide, an inhalant agent used extensively In anesthesia, also have antagonist property of NMDA receptors. The investigators hypothesize that prolonged treatment with N2O can alleviate chronic neuropathic pain of different causes (e.g. diabetic neuropathy, post herpetic neuralgia etc.).

Timeline

Start
2014-09
Primary completion
2015-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified 70 % Other

Indications